This is a Validated Antibody Database (VAD) review about human EFNB1, based on 4 published articles (read how Labome selects the articles), using EFNB1 antibody in all methods. It is aimed to help Labome visitors find the most suited EFNB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EFNB1 synonym: CFND; CFNS; EFB1; EFL3; EPLG2; Elk-L; LERK2; ephrin-B1; ELK ligand; eph-related receptor tyrosine kinase ligand 2
Invitrogen
mouse monoclonal (2D3E9) |
| In order to develop a novel synaptic junction preparation to characterize components of the synaptic cleft, Invitrogen EFNB1 antibody (Zymed, 37-8100) was used in western blot on rat samples at 2 ug/ml (tbl 1). PLoS ONE (2017) ncbi |
mouse monoclonal (2D3E9) |
| In order to report that ephrin-B3 specifies the synaptic localization of PSD-95, Invitrogen EFNB1 antibody (Thermo Fisher Scientific, 37-8100) was used in western blot on mouse samples at 1:1000 (fig 1). Nat Neurosci (2015) ncbi |
rabbit polyclonal |
| In order to study Eph/ephrin expression within the human cornea, Invitrogen EFNB1 antibody (Invitrogen, 34-3500) was used in immunohistochemistry on human samples at 1:50 (tbl 1). Exp Eye Res (2013) ncbi |
LifeSpan Biosciences
rabbit polyclonal |
| In order to test if HPV infection affects cellular proliferation by altering the localization of EphrinB1 during mitosis, LifeSpan Biosciences EFNB1 antibody (LifeSpan BioSciences, LS-C108001) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 3). Oncotarget (2015) ncbi |
Articles Reviewed
- Colbert P, Vermeer D, Wieking B, Lee J, Vermeer P. EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity. Oncotarget. 2015;6:953-68 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments